CDC42 and cervical squamous cell carcinoma: As of now, through bioinformatic analyses, we had partly understood the underlying driving factors of CDC42 upregulation in HPV-related cancer and its impact on the prognosis of CESC patients, but the potential contribution of these findings to clinical therapeutic development remained unclear.